Novel CRISPR-Cas12i system

A wild-type protein technology, which is applied in the direction of urinary system diseases, muscular system diseases, nervous system diseases, etc., can solve the problems of good or bad performance

Pending Publication Date: 2022-02-08
HUIGENE THERAPEUTICS CO LTD
View PDF23 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Later, more Cas12 proteins were discovered, including Cas12b (C2c1), Cas12c (C2c3), Cas12d (CasY), Cas12e (CasX), Cas12f (C2c10 / Cas14), Cas12k (C2c5), but each has its own advantages and disadvantages

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel CRISPR-Cas12i system
  • Novel CRISPR-Cas12i system
  • Novel CRISPR-Cas12i system

Examples

Experimental program
Comparison scheme
Effect test

Embodiment approach

[0056] 1. A Cas12i protein, which comprises the amino acid sequence shown in any one of SEQ ID NO:1-10 (preferably, SEQ ID NO:1-3 and 6, more preferably, SEQ ID NO:1) Have at least 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, Amino acid sequences that are 96%, 97%, 98%, 99%, 99.5% or 100% identical.

[0057] The Cas12i protein may also contain amino acid mutations that have no substantial effect on the catalytic activity (endonuclease cleavage activity) or nucleic acid binding function of Cas12i.

[0058] 2. The Cas12i protein according to any one of the preceding embodiments, wherein the Cas12i protein substantially lacks (for example, retains less than 50%, 40%, 35%, 30%, 27.5%, 25%, 22.5%, 20% %, 17.5%, 15%, 12.5%, 10%, 7.5%, 5%, 4%, 3%, 2.5%, 2%, 1% or lower) corresponding to wild-type Cas12i protein targeting and guide sequence Spacer-specific endonuclease cleavage activity of the target sequence of complementary target DNA.

[0059] ...

Embodiment 1

[0272] Embodiment 1: the identification of novel Cas12i protein

[0273] Download the metagenomic database (https: / / jgi.doe.gov / ) of the Joint Genome Institute (JGI), and get a total of 16TB of high-quality data. Over 6,000 metagenomic datasets were locally aligned with TBLASTN (https: / / blast.ncbi.nlm.nih.gov / ). Among them, 10 new Cas12i proteins were found in 4 groups of samples with different origins, which were respectively named SiCas12i, Si2Cas12i, WiCas12i, Wi2Cas12i, Wi3Cas12i, SaCas12i, Sa2Cas12i, Sa3Cas12i, WaCas12i and Wa2Cas12i. SiCas12i is 287 and 193 amino acids smaller than SpCas9 and LbCas12a, respectively.

[0274] The amino acid sequences of SiCas12i, Si2Cas12i, WiCas12i, Wi2Cas12i, Wi3Cas12i, SaCas12i, Sa2Cas12i, Sa3Cas12i, WaCas12i and Wa2Cas12i are respectively SEQ ID NO: 1-10, and the nucleotide coding sequences are respectively SEQ ID NO: 11-20. Four Cas12i-containing samples were annotated with CRISPR loci using PILERCR, and the DR sequences correspondi...

Embodiment 2

[0275] Example 2: Using a fluorescent reporter system to compare the cleavage activity of Cas12i and three kinds of control SpCas9, LbCas12a, Cas12i.3

[0276] In order to sensitively detect the cleavage activity of the CRISPR / Cas system, a reporter vector for transcribing BFP-P2A-GFxFP mRNA (BFP-P2A-GFxFP reporter vector, SEQ ID NO:31, figure 1 ). BFP expresses the coding sequence of blue fluorescent protein, and the blue fluorescence indicates that the reporter vector has successfully transfected the host cell. The GF and FP sequences in GFxFP are the N-terminal 561nt sequence and the C-terminal 609nt sequence of the green fluorescent protein gene EGFP, respectively, and the two sequences have a total overlap of 450nt. The middle of GFxFP is an insert fragment (SEQ ID NO:32), which contains the target sequence targeted by the CRISPR / Cas system (SEQ ID NO:33).

[0277] Most of the currently known Cas12 proteins recognize the 5'-T enriched PAM of double-stranded DNA, while C...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present disclosure provides a Cas12i protein comprising an amino acid sequence having at least 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, 99.5% or 100% identity with the amino acid sequence represented by any one of SEQ ID NO: 1-10 (preferably, SEQ ID NO: 1-3 and 6, more preferably, SEQ ID NO: 1). The present disclosure also provides an engineered, non-naturally occurring CRISPR-Cas system comprising: (1) the Cas12i protein or a polynucleotide encoding the Cas12i protein; and (2) a CRISPR RNA (crRNA) or a polynucleotide encoding the crRNA, the crRNA comprising: (i) a spacer sequence capable of hybridizing to a target sequence of a target DNA, and (ii) a direct repeat (DR) sequence linked to the spacer sequence capable of directing the binding of the Cas12i protein to the crRNA to form a CRISPR-Cas complex that targets the target sequence.

Description

technical field [0001] The present invention relates to a novel CRISPR-Cas12i system. Background technique [0002] Clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) genes, collectively known as CRISPR-Cas or CRISPR / Cas systems, are now understood to confer immunity against phage infection in bacteria and archaea. The CRISPR-Cas system of prokaryotic adaptive immunity is an extremely diverse set of effectors, non-coding elements, and locus structures that can be engineered for applications such as gene editing, target detection, and disease treatment. Zhang Feng and others discovered the Cas12a protein (called Cpf1 protein in the past), which can be used for gene editing and gene diagnosis. Later, more Cas12 proteins were discovered, including Cas12b (C2c1), Cas12c (C2c3), Cas12d (CasY), Cas12e (CasX), Cas12f (C2c10 / Cas14), Cas12k (C2c5), but each has its own advantages and disadvantages . [0003] Despite existing technologies...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12N9/22C12N15/55C12N15/113C12N15/85C12N15/65C12N5/10C12Q1/6816A61K48/00A61K38/46A61P35/00A61P35/02A61P31/18A61P31/22A61P25/00A61P27/06A61P27/02A61P25/16A61P25/28A61P25/14A61P25/18A61P25/24A61P25/36A61P43/00A61P21/00A61P13/12A61P3/06A61P7/06
CPCC12N9/22C12N15/113C12N15/85C12N15/65C12N5/0686C12Q1/6816A61K48/005A61K38/465A61P35/00A61P35/02A61P31/18A61P31/22A61P25/00A61P27/06A61P27/02A61P25/16A61P25/28A61P25/14A61P25/18A61P25/24A61P25/36A61P43/00A61P21/00A61P13/12A61P3/06A61P7/06C12N2310/20C12N2800/107C12N2510/00C12Q2521/327C12Q2525/151C12Q2525/161C12N15/102
Inventor 张海南孔祥锋陈绮佳
Owner HUIGENE THERAPEUTICS CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap